From: Hyperlactatemia in a group of HIV patients living in Yaounde-Cameroon
 | Odds ratio | 95% CI | p |
---|---|---|---|
Sex | Â | Â | Â |
 Male | 1.00 |  |  |
 Female | 2.25 | 0.79 – 6.42 | 0.130 |
Age groups (years) | Â | Â | Â |
 20 – 29 | 1.00 |  |  |
 30 – 39 | 0.42 | 0.07 – 2.57 | 0.347 |
 40 – 49 | 0.67 | 0.11 – 4.15 | 0.664 |
 ≥ 50 | 0.21 | 0.02 – 2.84 | 0.243 |
Duration of cumulative ART exposure | Â | Â | Â |
 < 5 years | 1.00 |  |  |
 ≥ 5 years | 2.59 | 0.87 – 7.72 | 0.089 |
ART exposure | Â | Â | Â |
 No | 1.00 |  |  |
 Yes | 3.22 | 0.70 – 14.93 | 0.134 |
CDC clinical stage | Â | Â | Â |
 A | 1.19 | 1.1 – 1.28 | 0.843 |
 C | 1.00 |  |  |
ART regimen | Â | Â | Â |
 First line | 10.91 | 1.37 – 86.70 | 0.024* |
 Second line | 1.00 |  |  |
First line AZT-regimens | Â | Â | Â |
 No | 1.00 |  |  |
 Yes | 1.02 | 0.32 – 3.32 | 0.969 |
First line TDF-regimens | Â | Â | Â |
 No | 1.00 |  |  |
 Yes | 1.17 | 0.35 – 3.97 | 0.797 |
First line 3TC-regimens | Â | Â | Â |
 No | 1.00 |  |  |
 Yes | 0.98 | 0.94 – 1.02 | 0.742 |